| Literature DB >> 28402851 |
Katharina Timper1, Jesse Lee Denson1, Sophie Marie Steculorum1, Christian Heilinger1, Linda Engström-Ruud1, Claudia Maria Wunderlich1, Stefan Rose-John2, F Thomas Wunderlich3, Jens Claus Brüning4.
Abstract
Interleukin (IL)-6 engages similar signaling mechanisms to leptin. Here, we find that central application of IL-6 in mice suppresses feeding and improves glucose tolerance. In contrast to leptin, whose action is attenuated in obesity, the ability of IL-6 to suppress feeding is enhanced in obese mice. IL-6 suppresses feeding in the absence of neuronal IL-6-receptor (IL-6R) expression in hypothalamic or all forebrain neurons of mice. Conversely, obese mice exhibit increased soluble IL-6R levels in the cerebrospinal fluid. Blocking IL-6 trans-signaling in the CNS abrogates the ability of IL-6 to suppress feeding. Furthermore, gp130 expression is enhanced in the paraventricular nucleus of the hypothalamus (PVH) of obese mice, and deletion of gp130 in the PVH attenuates the beneficial central IL-6 effects on metabolism. Collectively, these experiments indicate that IL-6 trans-signaling is enhanced in the CNS of obese mice, allowing IL-6 to exert its beneficial metabolic effects even under conditions of leptin resistance.Entities:
Keywords: CNS; energy homeostasis; glucose homeostasis; interleukin-6; interleukin-6 trans-signaling; obesity
Mesh:
Substances:
Year: 2017 PMID: 28402851 DOI: 10.1016/j.celrep.2017.03.043
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423